strain	case_id	genotype	host_age	host_sex	organism	study_id	phenotype	isolate_id	population	body_product	host_age_bin	host_disease	sequenced_by	vaccine_name	antimalarials	host_age_unit	study_site_id	other_host_sex	other_organism	travel_history	anatomical_part	host_subject_id	other_phenotype	sequencing_date	infectious_agent	host_health_state	assembly_accession	host_disease_stage	lineage_clade_name	other_body_product	other_host_disease	resistance_variant	signs_and_symptoms	symptom_onset_date	anatomical_material	biosample_accession	host_health_outcome	other_antimalarials	purpose_of_sampling	sample_collected_by	vaccination_history	drug_resistance_type	geo_loc_name_country	host_scientific_name	resistance_gene_name	other_anatomical_part	purpose_of_sequencing	sequencing_assay_type	sequencing_instrument	virulence_factor_gene	environmental_material	resistance_gene_symbol	sample_collection_date	bioinformatics_protocol	depth_of_coverage_value	host_vaccination_status	other_host_health_state	sequence_read_accession	other_host_disease_stage	other_resistance_variant	breadth_of_coverage_value	other_anatomical_material	other_host_health_outcome	other_sample_collected_by	diagnostic_resistance_type	other_drug_resistance_type	other_host_scientific_name	other_resistance_gene_name	reference_genome_accession	biospecimen_processing_date	other_purpose_of_sequencing	other_sequencing_assay_type	other_sequencing_instrument	other_environmental_material	specimen_collector_sample_id	diagnostic_procedure_of_malaria	other_diagnostic_resistance_type	prior_antimalarial_treatment_agent	prior_malaria_infection_isolate_id	host_residence_geo_loc_name_country	geo_loc_name_state_province_territory	other_diagnostic_procedure_of_malaria	location_of_exposure_geo_loc_name_country	prior_antibiotic_treatment_during_prior_malaria_infection
malaria_human_strain_001	MALARIA_HUMAN-001	malaria_human_genotype_001	25	Female	Plasmodium Falciparum	MHUM-2024	malaria_human_phenotype_001	MALARIA_HUMAN-001	Human Population	Feces	0 - 9	Malaria	malaria_human_sequenced_by_001	RTS,S (Mosquirx), Glaxosmithkline (GSK) And Partners	malaria_human_antimalarials_001	Month	malaria_human_study_site_id_001	malaria_human_other_host_sex_001	malaria_human_other_organism_001	malaria_human_travel_history_001	Buccal Mucosa	malaria_human_host_subject_id_001	malaria_human_other_phenotype_001	2024-01-15	malaria_human_infectious_agent_001	Asymptomatic	SRR100000	Blood Stage	malaria_human_lineage_clade_name_001	malaria_human_other_body_product_001	malaria_human_other_host_disease_001	HRP2 Deletion	Chills (Sudden Cold Sensation)	2024-01-15	Blood Clot	CP100000	Deceased	malaria_human_other_antimalarials_001	Research	Programa Nacional De Controlo Da Malária (Angola)	malaria_human_vaccination_history_001	Antibiotic Resistance	Algeria	Homo Sapiens	Histidine-Rich Protein 2 (Diagnostic Resistance)	malaria_human_other_anatomical_part_001	Baseline Surveillance (Random Sampling)	Amplicon Sequencing Assay	Illumina	malaria_human_virulence_factor_gene_001	Animal Carcass	HRP2 (Diagnostic Resistance)	2024-01-15	malaria_human_bioinformatics_protocol_001	50	Fully Vaccinated	malaria_human_other_host_health_state_001	CP100000	malaria_human_other_host_disease_stage_001	malaria_human_other_resistance_variant_001	malaria_human_breadth_of_coverage_value_001	malaria_human_other_anatomical_material_001	malaria_human_other_host_health_outcome_001	malaria_human_other_sample_collected_by_001	malaria_human_diagnostic_resistance_type_001	malaria_human_other_drug_resistance_type_001	malaria_human_other_host_scientific_name_001	malaria_human_other_resistance_gene_name_001	SAMN100000	2024-01-15	malaria_human_other_purpose_of_sequencing_001	malaria_human_other_sequencing_assay_type_001	malaria_human_other_sequencing_instrument_001	malaria_human_other_environmental_material_001	SPEC-MALARIA_HUMAN-001	malaria_human_diagnostic_procedure_of_malaria_001	malaria_human_other_diagnostic_resistance_type_001	malaria_human_prior_antimalarial_treatment_agent_001	MALARIA_HUMAN-001	Algeria	Adrar	malaria_human_other_diagnostic_procedure_of_malaria_001	Afghanistan	malaria_human_prior_antibiotic_treatment_during_prior_malaria_infection_001
malaria_human_strain_002	MALARIA_HUMAN-002	malaria_human_genotype_002	35	Male	Plasmodium Vivax	MHUM-2025	malaria_human_phenotype_002	MALARIA_HUMAN-002	Human Population In Malarial Areas	Fluid (Discharge)	10 - 19	Blackwater Fever	malaria_human_sequenced_by_002	R21/Matrix-M™, Serum Institute Of India Private Ltd (SII)	malaria_human_antimalarials_002	Year	malaria_human_study_site_id_002	malaria_human_other_host_sex_002	malaria_human_other_organism_002	malaria_human_travel_history_002	Cheek	malaria_human_host_subject_id_002	malaria_human_other_phenotype_002	2024-01-22	malaria_human_infectious_agent_002	Deceased	SAMN101000	Blood Gametocyte Stage	malaria_human_lineage_clade_name_002	malaria_human_other_body_product_002	malaria_human_other_host_disease_002	HRP2 Mutation	Fatigue (Tiredness)	2024-01-22	Blood Serum	SAMN101000	Deteriorating	malaria_human_other_antimalarials_002	Baseline Surveillance	Instituto Nacional De Investigação Em Saúde (Angola)	malaria_human_vaccination_history_002	Resistance To Single Antimalarial Drug	Angola	Rodentia	Histidine-Rich Protein 3 (Diagnostic Resistance)	malaria_human_other_anatomical_part_002	Targeted Surveillance (Non-Random Sampling)	18S Ribosomal Gene Sequencing Assay	Illumina Genome Analyzer	malaria_human_virulence_factor_gene_002	Clothing	HRP3 (Diagnostic Resistance)	2024-01-22	malaria_human_bioinformatics_protocol_002	60	Partially Vaccinated	malaria_human_other_host_health_state_002	SAMN101000	malaria_human_other_host_disease_stage_002	malaria_human_other_resistance_variant_002	malaria_human_breadth_of_coverage_value_002	malaria_human_other_anatomical_material_002	malaria_human_other_host_health_outcome_002	malaria_human_other_sample_collected_by_002	malaria_human_diagnostic_resistance_type_002	malaria_human_other_drug_resistance_type_002	malaria_human_other_host_scientific_name_002	malaria_human_other_resistance_gene_name_002	SRR101000	2024-01-22	malaria_human_other_purpose_of_sequencing_002	malaria_human_other_sequencing_assay_type_002	malaria_human_other_sequencing_instrument_002	malaria_human_other_environmental_material_002	SPEC-MALARIA_HUMAN-002	malaria_human_diagnostic_procedure_of_malaria_002	malaria_human_other_diagnostic_resistance_type_002	malaria_human_prior_antimalarial_treatment_agent_002	MALARIA_HUMAN-002	Angola	Aïn Defla	malaria_human_other_diagnostic_procedure_of_malaria_002	Albania	malaria_human_prior_antibiotic_treatment_during_prior_malaria_infection_002
malaria_human_strain_003	MALARIA_HUMAN-003	malaria_human_genotype_003	45	Not Applicable	Plasmodium Ovale	MHUM-2026	malaria_human_phenotype_003	MALARIA_HUMAN-003	Human Population Of Immune Individuals	Mucus	20 - 29	Cerebral Malaria	malaria_human_sequenced_by_003	Not Applicable	malaria_human_antimalarials_003	Not Applicable	malaria_human_study_site_id_003	malaria_human_other_host_sex_003	malaria_human_other_organism_003	malaria_human_travel_history_003	Tongue	malaria_human_host_subject_id_003	malaria_human_other_phenotype_003	2024-01-29	malaria_human_infectious_agent_003	Healthy	CP102000	Female Blood Gametocyte Stage	malaria_human_lineage_clade_name_003	malaria_human_other_body_product_003	malaria_human_other_host_disease_003	HRP3 Deletion	Fever	2024-01-29	Blood Plasma	SRR102000	Recovered	malaria_human_other_antimalarials_003	Cluster/Outbreak Investigation	Agostinho Neto University, Faculty Of Medicine (Angola)	malaria_human_vaccination_history_003	Antifolate Resistance	Benin	Mus	Parasite Lactate Dehydrogenase (pLDH) (Diagnostic Resistance)	malaria_human_other_anatomical_part_003	Priority Surveillance Project	Whole Genome Sequencing Assay	Illumina Genome Analyzer II	malaria_human_virulence_factor_gene_003	Soil	PLDH (Diagnostic Resistance)	2024-01-29	malaria_human_bioinformatics_protocol_003	70	Not Vaccinated	malaria_human_other_host_health_state_003	SAMN102000	malaria_human_other_host_disease_stage_003	malaria_human_other_resistance_variant_003	malaria_human_breadth_of_coverage_value_003	malaria_human_other_anatomical_material_003	malaria_human_other_host_health_outcome_003	malaria_human_other_sample_collected_by_003	malaria_human_diagnostic_resistance_type_003	malaria_human_other_drug_resistance_type_003	malaria_human_other_host_scientific_name_003	malaria_human_other_resistance_gene_name_003	SRR102000	2024-01-29	malaria_human_other_purpose_of_sequencing_003	malaria_human_other_sequencing_assay_type_003	malaria_human_other_sequencing_instrument_003	malaria_human_other_environmental_material_003	SPEC-MALARIA_HUMAN-003	malaria_human_diagnostic_procedure_of_malaria_003	malaria_human_other_diagnostic_resistance_type_003	malaria_human_prior_antimalarial_treatment_agent_003	MALARIA_HUMAN-003	Benin	Aïn Témouchent	malaria_human_other_diagnostic_procedure_of_malaria_003	Algeria	malaria_human_prior_antibiotic_treatment_during_prior_malaria_infection_003
